Literature DB >> 16707398

Time course of exhaled hydrogen peroxide and nitric oxide during chemotherapy.

A R Wewel1, J A M Crusius, U Gatzemeier, M Heckmayr, G Becher, H Magnussen, R A Jörres, O Holz.   

Abstract

This study was designed to assess the effect of differential leukocyte depletion during chemotherapy by monitoring the levels of exhaled hydrogen peroxide H2O2 and nitric oxide (F(eNO)) present. In 39 patients with lung cancer (chronic obstructive pulmonary disorder up to stage II, median forced expiratory volume in one second 78% predicted), measurements were performed before a cycle of therapy (day 1), at least once during the cycle (day 8: n = 34; day 15: n = 19), and afterwards (days 21-29). There were significant changes in the level of H2O2, F(eNO) and peripheral blood cell differentials over the visits. The level of H2O2 was decreased only on day 15, with a median (difference between the upper and lower quartiles) fall of 31 (57)%, while F(eNO) was reduced only on day 8, by 22 (40)%. Neutrophil numbers were unchanged on day 8 and decreased by 59 (48)% on day 15, while monocyte numbers were decreased on day 8 by 87 (39)%. On days 21-29, values had returned to baseline. Taken together with previous findings, the parallel course of levels of exhaled hydrogen peroxide and neutrophil counts suggests that a major part of exhaled hydrogen peroxide is due to neutrophils via the conducting airways. In contrast, the production of exhaled nitric oxide seems to be primarily associated with monocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16707398     DOI: 10.1183/09031936.06.00101705

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Elevated exhalation of hydrogen peroxide in patients with non-small cell lung cancer is not affected by chemotherapy.

Authors:  Agnieszka Krawczyk; Dariusz Nowak; Piotr Jan Nowak; Gianluca Padula; Sylwia Kwiatkowska
Journal:  Redox Rep       Date:  2016-09-09       Impact factor: 4.412

2.  Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today.

Authors:  Anastasios Kallianos; Sotirios Tsimpoukis; Paul Zarogoulidis; Kaid Darwiche; Andriani Charpidou; Ilias Tsioulis; Georgia Trakada; Konstantinos Porpodis; Dionysios Spyratos; Athanasios Panoutsopoulos; Lemonia Veletza; Konstantinos Kostopoulos; Charalampos Kostopoulos; Ilias Karapantzos; Kosmas Tsakiridis; Wolfgang Hohenforst-Schmidt; Konstantinos Zarogoulidis; Aggeliki Rapti; Konstantinos Syrigos
Journal:  Onco Targets Ther       Date:  2013-05-31       Impact factor: 4.147

3.  Hydrogen peroxide in exhaled air: a source of error, a paradox and its resolution.

Authors:  Stefan Peters; Angelika Kronseder; Stefan Karrasch; Petra A Neff; Matz Haaks; Andreas R Koczulla; Petra Reinhold; Dennis Nowak; Rudolf A Jörres
Journal:  ERJ Open Res       Date:  2016-06-17

4.  Measurement of exhaled nitric oxide and serum surfactant protein D levels for monitoring radiation pneumonitis following thoracic radiotherapy.

Authors:  Hideya Yamazaki; Norihiro Aibe; Satoaki Nakamura; Naomi Sasaki; Gen Suzuki; Ken Yoshida; Kei Yamada; Masahiko Koizumi; Taichiro Arimoto; Yoshinobu Iwasaki; Yoshiko Kaneko; Koichi Takayama
Journal:  Oncol Lett       Date:  2017-08-01       Impact factor: 2.967

5.  Coexistence of diffuse panbronchiolitis and asthma: reciprocity of neutrophilic and eosinophilic inflammation.

Authors:  Kiyoshi Takeyama; Yuri Shimizu; Masanobu Ishii; Hiroko Hara; Mitsuko Kondo; Jun Tamaoki
Journal:  Respirol Case Rep       Date:  2017-04-03

6.  Nitric oxide in occurrence, progress and therapy of lung Cancer: a systemic review and meta-analysis.

Authors:  Hongbin Zhou; Jiuke Li; Zhewen Chen; Ying Chen; Sa Ye
Journal:  BMC Cancer       Date:  2021-06-08       Impact factor: 4.430

7.  Can exhaled NO fraction predict radiotherapy-induced lung toxicity in lung cancer patients?

Authors:  Irina Enache; Georges Noel; M Young Jeung; Nicolas Meyer; Monique Oswald-Mammosser; Emile Urban-Kraemer; Catherine Schumacher; Bernard Geny; Elisabeth Quoix; Anne Charloux
Journal:  Radiat Oncol       Date:  2012-07-28       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.